优宁维：公司围绕一站式平台极致战略和抗体极致战略，致力于通过围绕抗体上下游应用领域寻找相关标的企业

Core Viewpoint - The company, Uningwei (301166), is focused on its one-stop platform strategy and antibody strategy, aiming to find relevant target companies in the upstream and downstream application fields of antibodies for synergistic development with its existing business [1] Group 1 - The company emphasizes strict compliance with information disclosure regulations and will announce any substantial progress or transactions that meet disclosure standards in a timely manner [1]